257: Cardiovascular risk prevalence in high risk primary care patients not treated with lipid-lowering treatment in France, results of an online study

PurposeFew data exists on high cardiovascular risk (HCVR) prevalence within a primary prevention population. The goal of the study was to assess HCVR distribution, according to SCORE, in France for high-risk primary care patients not treated with lipid-lowering drug.MethodsThis observational study was conducted over a week on a representative sample of French general practitioners (GP). All consulting primary care men/women ≥50/60 y, with at least one other CVR factor (smoking, high blood pressure (HBP), type 2 diabetes, HDL-c<0.40g/L), not treated for dyslipidemia were included in the study. GP filled-in an on line questionnaire that enabled SCORE calculation.ResultsGPs (n=1147) included 9049 patients with the following characteristics: mean age: 68 y; male: 57%; LDLc>1.3g/L: 57%; smoking: 21%; HBP: 44%; type 2 diabetes: 21% HDL-c<0.4g/L: 16%.According to SCORE, HCVR prevalence reached 50% in total population (male: 49%, female: 51%). 50% of HCVR men/women were older than >72.4/78.8 y. HCVR patients were older by 7.7/6.8 y for male/female (p <0.01) than non-HCVR patients. Other significantly more frequent characteristics in high CVR population are: HDL≥0.6g/L (38%), untreated or uncontrolled HBP (53%) and left ventricular hypertrophy (8%). Obesity is less frequent (15%) in high CVR population. Highest HCVR prevalence was observed in the Mediterranean population (54%), and lowest (47%) in the Northeast population (p